FindTrial
Sign In

Blood Glucose Management in Diabetic COVID19 Patients

TO STUDY ASSOCIATION OF BLOOD GLUCOSE CONTROL AND OUTCOME OF COVID 19 ILLNESS IN DIABETIC PATIENTS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/029059
Enrollment
100
Registered
2020-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Inpatients in General Medicine with diagnosis of COVID 19 infection (Laboratory confirmed) 2. Patients with pre existing diabetes or New onset diabetic patients.

Exclusion criteria

Exclusion criteria: 1. AGE Less than 18 YEARS 2. Acute Myocardial infarction 3. Acute cerebral vascular stroke 4. Pregnant Female 5. Impaired glucose tolerance

Design outcomes

Primary

MeasureTime frame
Clinical Deterioration and Control of Blood GlucoseTimepoint: At Baseline, Every 3rd Day till Discharge/Death—

Secondary

MeasureTime frame
1. In hospital stay (Duration and Type of stay-ICU or ward) 2.Mortality 3. Effect of glycemic control on level of inflammatory markersTimepoint: At Baseline, Every 3rd Day till Discharge/Death—

Countries

India

Contacts

Public ContactDr Janakkumar R Khambholja

Smt NHL Municipal Medical College

patelsuhag9090@gmail.com7621886071

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026